Facial granulomatous nodules during etanercept treatment for psoriasis

International Journal of Dermatology

Volumn 48, Issue 9, 2009, Pages 1025-1027

  Samimi, Mahtab ^a,b   Lorette, Gérard ^a,b   Machet, Laurent ^a,b   de Muret, Anne ^a,b   Watier, Hervé ^a,b   Maruani, Annabel ^a,b  

^a UNIVERSITÉ DE TOURS   (France)

^b Hospital Center   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT;

ADULT; ASTHENIA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DRUG WITHDRAWAL; FACE DISORDER; GRANULOMATOUS INFLAMMATION; GRANULOMATOUS SKIN DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LETTER; MALE; PSORIATIC ARTHRITIS; SARCOIDOSIS; SKIN NODULE;

ADULT; DRUG ERUPTIONS; FACIAL DERMATOSES; GRANULOMA; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; MALE; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; SARCOIDOSIS;

EID: 69249139917     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2009.04080.x     Document Type: Letter

References (10)

1. Vavricka SR, Wettstein T, Speich R, et al. Pulmonary granulomas after tumor necrosis factor alpha antagonist therapy. Thorax 2003; 58: 278-279.
2. Peno-Green L, Lluberas T, Kingsley T, et al. Lung injury linked to etanercept therapy. Chest 2002; 122: 1858-1860.
3. Bachmeyer C, Blum L, Petitjean B, et al. Granulomatous tattoo reaction in a patient treated with etanercept. Letter to Editor. J Eur Acad Dermatol Venereol 2007; 21: 550-551.
4. Gonzales-Lopez M, Blanco R, Gonzales-Vela MC, et al. Development of sarcoidosis during etanercept therapy. Arthritis Rheum 2006; 55: 817-820.
5. Verschueren K, Van Essche E, Verschueren P, et al. Development of sarcoidosis in etanercept-treated rheumatoid patients. Clin Rheumatol 2007; 26: 1969-1971.
6. Phillips K, Weinblatt M. Granulomatous lung disease occurring during etanercept treatment. Arthritis Rheum 2005; 53: 618-620.
7. Farah RE, Shay MD. Pulmonary sarcoidosis associated with etanercept therapy. Pharmacotherapy 2007; 27: 1446-1448.
8. Yousem S, Dacic S. Pulmonary lymphohistiocytic reactions temporally related to etanercept therapy. Mod Pathol 2005; 18: 651-655.
9. Kudrin A, Chilvers E, Ginawi A, et.al. Sarcoid-like granulomatous disease following etanercept treatment for rheumatoid arthritis. J Rheumatol 2007; 34: 648-649.
10. Furst D, Wallis R, Broder M, et al. TNF antagonists: Different kinetics and/or mechanisms of action may explain differences in the risk for developing granulomatous infection. Semin Arthritis Rheum 2006; 36: 159-167.